Atlas Trials

Impact of the Addition of Metformin to Abiraterone in Metastatic Prostate Cancer Patients

Clinical trial NCT01677897 · COMPLETED

Trial details

NCT number
NCT01677897
Sponsor
Kantonsspital Graubünden
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Prostate Cancer
Start date
2013-08-01
Primary completion
2017-12-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.